About: http://data.cimple.eu/news-article/3c1a5c365fcbc10cf6cab9aac685023f4f39e2deb3db17bee3dedaf2

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/3c1a5c365fcbc10cf6cab9aac685023f4f39e2deb3db17bee3dedaf2 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	French pharmaceuticals giant Sanofi, which was beaten by competitors to a Covid-19 vaccine, said Monday it would spend 400 million euros ($475 million) on building a new plant that can produce several vaccines at once. The high-tech factory will be located in Singapore and will be operational in the first quarter of 2026, the company said, adding that construction would start this summer. "The new site will provide Sanofi with the ability to produce innovative vaccines on a massive scale for Asia, and quickly respond to future pandemic risks," it added. Sanofi dealt a huge blow to France's pride in its pharmaceutical sector by being trounced in the race to develop a Covid-19 vaccine. The world's third-biggest vaccine maker before the pandemic has said its vaccine candidate will not be ready before late 2021 at the earliest. In the interim it has been reduced to helping produce vaccines for its rivals Pfizer and Johnson & Johnson. The Paris-based group said on Monday that, whereas its other factories can only produce a single vaccine at a time, the Singapore facility would be able to produce three or four. The factory will also be able to leverage "multiple vaccine manufacturing technology platforms based on different cell types" which would allow it to roll out a specific vaccine faster "depending on public health needs", it added. The announcement is the third of its type by Sanofi since the start of the coronavirus pandemic. It also plans new investments in France and Canada. jdy/cb/rl
schema:headline	France's Sanofi to invest 400 mn euros in Asia vaccine plant
schema:mentions	Cornerback Pharmaceutical industry Johnson & Johnson Asia Public health Singapore Canada Pandemic France Pfizer Vaccine Severe acute respiratory syndrome coronavirus 2 Coronavirus disease 2019 The Factory Sanofi
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2021-04-12 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	neutral sentiment
http://data.cimple...readability_score	79 (xsd:integer)

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 11 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software